PortfoliosLab logoPortfoliosLab logo
SKYE vs. OPEN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

SKYE vs. OPEN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Skye Bioscience, Inc (SKYE) and Opendoor Technologies Inc. (OPEN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, SKYE achieves a 2.71% return, which is significantly higher than OPEN's -26.07% return.


SKYE

1D
5.02%
1M
-10.75%
YTD
2.71%
6M
-36.36%
1Y
-68.31%
3Y*
-41.13%
5Y*
-54.71%
10Y*
-40.24%

OPEN

1D
-2.49%
1M
-13.97%
YTD
-26.07%
6M
-38.87%
1Y
555.14%
3Y*
22.89%
5Y*
-24.01%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

SKYE vs. OPEN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
SKYE
Skye Bioscience, Inc
2.71%-73.51%4.04%-32.84%-68.85%30.00%-66.39%
OPEN
Opendoor Technologies Inc.
-26.07%276.52%-64.29%286.21%-92.06%-35.72%110.39%

Correlation

The correlation between SKYE and OPEN is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.06

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Jun 19, 2020

0.06

Fundamentals

Market Cap

SKYE:

$30.55M

OPEN:

$4.13B

EPS

SKYE:

-$1.45

OPEN:

-$1.74

PB Ratio

SKYE:

3.39

OPEN:

4.33

Total Revenue (TTM)

SKYE:

$0.00

OPEN:

$3.94B

Gross Profit (TTM)

SKYE:

-$180.01K

OPEN:

$312.00M

EBITDA (TTM)

SKYE:

$10.92M

OPEN:

-$1.25B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

SKYE vs. OPEN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SKYE
SKYE Risk / Return Rank: 1919
Overall Rank
SKYE Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
SKYE Sortino Ratio Rank: 2222
Sortino Ratio Rank
SKYE Omega Ratio Rank: 2121
Omega Ratio Rank
SKYE Calmar Ratio Rank: 1212
Calmar Ratio Rank
SKYE Martin Ratio Rank: 2121
Martin Ratio Rank

OPEN
OPEN Risk / Return Rank: 9595
Overall Rank
OPEN Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
OPEN Sortino Ratio Rank: 9595
Sortino Ratio Rank
OPEN Omega Ratio Rank: 9292
Omega Ratio Rank
OPEN Calmar Ratio Rank: 9797
Calmar Ratio Rank
OPEN Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SKYE vs. OPEN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Skye Bioscience, Inc (SKYE) and Opendoor Technologies Inc. (OPEN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


SKYEOPENDifference
Sharpe ratioReturn per unit of total volatility

-4.08

Sortino ratioReturn per unit of downside risk

-4.48

Omega ratioGain probability vs. loss probability

0.94

1.47

-0.53

Calmar ratioReturn relative to maximum drawdown

-0.78

9.66

-10.44

Martin ratioReturn relative to average drawdown

-1.04

15.03

-16.07

SKYE vs. OPEN - Sharpe Ratio Comparison

The current SKYE Sharpe Ratio is -0.59, which is lower than the OPEN Sharpe Ratio of 3.48. The chart below compares the historical Sharpe Ratios of SKYE and OPEN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


SKYEOPENDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.59

3.48

-4.08

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.42

-0.21

-0.21

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.36

-0.13

-0.23

Drawdowns

SKYE vs. OPEN - Drawdown Comparison

The maximum SKYE drawdown since its inception was -99.96%, roughly equal to the maximum OPEN drawdown of -98.57%. Use the drawdown chart below to compare losses from any high point for SKYE and OPEN.


Loading charts...

Drawdown Indicators


SKYEOPENDifference

Max Drawdown

Largest peak-to-trough decline

-99.96%

-98.57%

-1.39%

Max Drawdown (1Y)

Largest decline over 1 year

-87.85%

-57.96%

-29.89%

Max Drawdown (3Y)

Largest decline over 3 years

-96.79%

-90.28%

-6.51%

Max Drawdown (5Y)

Largest decline over 5 years

-98.66%

-97.93%

-0.73%

Max Drawdown (10Y)

Largest decline over 10 years

-99.83%

Current Drawdown

Current decline from peak

-99.94%

-87.59%

-12.35%

Average Drawdown

Average peak-to-trough decline

-94.95%

-74.59%

-20.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

65.76%

37.43%

+28.33%

Volatility

SKYE vs. OPEN - Volatility Comparison

Skye Bioscience, Inc (SKYE) has a higher volatility of 28.64% compared to Opendoor Technologies Inc. (OPEN) at 21.37%. This indicates that SKYE's price experiences larger fluctuations and is considered to be riskier than OPEN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


SKYEOPENDifference

Volatility (1M)

Calculated over the trailing 1-month period

28.64%

21.37%

+7.27%

Volatility (6M)

Calculated over the trailing 6-month period

63.38%

52.74%

+10.64%

Volatility (1Y)

Calculated over the trailing 1-year period

115.33%

161.11%

-45.78%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

130.81%

113.51%

+17.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

137.31%

110.45%

+26.86%

Dividends

SKYE vs. OPEN - Dividend Comparison

Neither SKYE nor OPEN has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

SKYE vs. OPEN - Financials Comparison

This section allows you to compare key financial metrics between Skye Bioscience, Inc and Opendoor Technologies Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B202220232024202520260
720.00M
(SKYE) Total Revenue
(OPEN) Total Revenue
Values in USD except per share items

Frequently Asked Questions


SKYE and OPEN have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SKYE has higher volatility (28.64%) compared to OPEN (21.37%). In terms of maximum drawdown, SKYE dropped -99.96% vs OPEN's -98.57%.

OPEN currently has the higher Sharpe Ratio (3.48 vs -0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for SKYE and OPEN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer